1-U

CURRENT REPORT PURSUANT TO REGULATION A

Company: 20/20 Biolabs, Inc.
Filed: February 25, 2021
Period of Report: February 25, 2021
Accession Number: 0001213900-21-011667

View Document ↗ View on SEC.gov ↗